| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.014 | 0.8 |